Articles
Measuring productive innovation (part II)

Measuring productive innovation (part II)

Following on from the first part of this video interview, pharmaphorum looks at how pharma companies can foster a culture of innovation. In part II of this three part interview, we reviewed which companies had not scored so highly and how they could improve their culture of innovation and index ranking…

Articles
An Executive Intelligence protocol: (part II)

An Executive Intelligence protocol: (part II)

In the second of their two-part series Caroline Dawe and Sue Wright continue to explore the concept of the Executive Intelligence protocol, this time looking at the Information cycle and the Communications Cycle. The Information Cycle looks at the progress of information as it is defined, identified and used by the EI function and …

Articles
What is the role of the patient in CME?

What is the role of the patient in CME?

David Williams discusses the topics addressed at the annual European CME Forum meeting and questions the merits of patient involvement in CME outcome measures. Many recent articles both here on pharmaphorum and elsewhere are recounting the changing world of pharma. The once secure and…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more